retatrutide prescribing information reconstitution How should be reconstituted? Retatrutide | Research Grade Peptide

This surpasses Tirzepatide (Zepbound) at 20.9% and Semaglutide (Wegovy) at 14.9%, making it the strongest pharmaceutical weight loss option ever studied

Diabetes Obes Metab 21(6):14981501 Vinciguerra F et al (2024) Efficacy of high-dose Liraglutide 3.0 mg in patients with poor response to bariatric surgery: real-world experience and updated meta-analysis

The three receptors it targets are: GLP-1 receptors : Help control appetite and slow digestion GIP receptors : Support insulin function and glucose regulation Glucagon receptors : Promote energy expenditure and fat burning This triple-action approach sets Retatrutide apart from current FDA-approved medications, such as semaglutide (found in Ozempic and Wegovy), which only target GLP-1 receptors, and tirzepatide (Mounjaro and Zepbound), which targets both GLP-1 and GIP receptors

Preparing the patient for what to expect fosters realistic expectations, builds trust, and encourages adherence to therapy

It is a hormone your intestines release after every meal, a chemical signal between your gut and your brain that says Slow down, youve had enough

Celebration doesn't mean stopping